This website has been commissioned by Ipsen Pharmaceuticals Ltd. and is intended for Irish Healthcare Professionals. If you are not a Healthcare Professional, please click here.
Adverse event reporting information is available at the bottom of this webpage.

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex)
Dysport<sup>®</sup> (<em>Clostridium botulinum</em> type A toxin-haemagglutinin complex)

Dysport® patient record booklet

Adult Spasticity File
48 pages

This booklet is designed to help patients taking Dysport® keep track of their injections and appointments. It allows them to record symptoms and any side effects and track progress towards their personal treatment goals.

DYS-IE-000957 | August 2025

Dysport<sup>®</sup> patient record booklet
Explore more Adult Spasticity Resources

Explore more Adult Spasticity Resources

Browse

To access relevant information about Adult Spasticity, please choose one of the following options:

Adverse events should be reported.
Reporting forms and information can be found at www.hpra.ie or e-mail medsafety@hpra.ie.
The HPRA can also be contacted on +353 16764971. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256.

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to the HPRA. Reporting forms and information can be found at www.hpra.ie or email medsafety@hpra.ie. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on +353 1 8098256. By reporting side effects, you can help provide more information on the safety of this medicine.